On-demand educational resources (e-learning, videos and slide site) are now available following a successful NTRK CONNECT Experts Knowledge Share event delivering practical insights and experiences on the diagnosis and treatment of TRK fusion-positive cancer. A number of adult cancer cases were discussed including lung cancer, GI cancer, sarcoma and thyroid cancer.
Patient case reports: from diagnosis to treatment of TRK-fusion positive cancer
The key clinical takeaways from this accredited e-learning are:
- There are a range testing approaches and diagnostic algorithms available to identify patients with TRK fusion-positive cancers
- Practical guidance is available on how to test for NTRK fusions in many cancers including lung, sarcoma, GI and thyroid cancer
- The two first-generation TRK inhibitors, larotrectinib and entrectinib, have demonstrated robust efficacy and safety in many cancers
Take the e-learning and claim your CME credit.